T9	Exp 211 216	which
T10	Exp 295 331	the transcription factor requirement
T11	Exp 402 424	the lymphoid cell line
T12	Exp 452 456	that
T13	Exp 433 444	The results
T14	Exp 457 471	the activation
T15	Exp 551 558	the Oct
T16	Exp 611 633	the Sp 1-binding sites
T17	Exp 639 651	the enhancer
T18	Exp 728 739	the removal
T19	Exp 743 767	the octamer-binding site
T20	Exp 819 834	both cell types
T21	Exp 971 976	which
T22	Exp 1024 1029	which
T23	Exp 951 955	both
T24	Exp 890 902	the capacity
T25	Exp 1039 1089	the predominantly expressed octamer-binding factor
T26	Exp 1125 1136	our results
T27	Exp 1140 1144	that
T28	Exp 1091 1121	The most likely interpretation
T29	Exp 1150 1185	the ubiquitous transcription factor
T30	Exp 1198 1238	the B-cell-specific transcription factor
T31	Exp 1377 1382	which
T32	Exp 1503 1508	which
T33	Exp 1605 1609	when
T34	Exp 1284 1295	The results
T35	Exp 1351 1376	the transcription factors
T36	Exp 1391 1398	the Oct
T37	Exp 1403 1428	the adjacent Sp 1-binding
T38	Exp 1610 1639	the weak octamer-binding site
T39	Exp 1589 1604	both cell types
R7	Coref Anaphora:T9 Antecedent:T40
R8	Coref Anaphora:T21 Antecedent:T41
R9	Coref Anaphora:T22 Antecedent:T42
R10	Coref Anaphora:T25 Antecedent:T3
R11	Coref Anaphora:T31 Antecedent:T35
R12	Coref Anaphora:T32 Antecedent:T43
T1	Protein 266 270	Sp 1
T2	Protein 615 619	Sp 1
T3	Protein 982 987	OTF-1
T4	Protein 1030 1035	OTF-2
T5	Protein 1187 1192	OTF-1
T6	Protein 1240 1245	OTF-2
T7	Protein 1416 1420	Sp 1
T8	Protein 1659 1663	Sp 1
T40	Exp 184 209	a distal enhancer element
T41	Exp 956 966	HeLa cells
T42	Exp 1009 1020	BJA-B cells
T43	Exp 1492 1502	a template
